Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-0158PMID 16912178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

  2006cited by this paper
• Inflammation in epithelial skin tumours: old stories and new ideas.

  2006cited by this paper
• Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial.

  2006cited by this paper
• Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.

  2005cited by this paper
• Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

  2005cited by this paper
• The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma.

  2004cited by this paper
• Hematopoietic cytokines as tumor markers.

  2004cited by this paper
• Expression of G-CSF and GM-CSF in Human Meningiomas Correlates with Increased Tumor Proliferation and Vascularization

  2004cited by this paper
• Friends or foes — bipolar effects of the tumour stroma in cancer

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Prognostic relevance of cell proliferation in head and neck tumors.

  2004cited by this paper
• Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma.

  2004cited by this paper
• Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells.

  2004cited by this paper
• Regulation of myeloid development and function by colony stimulating factors.

  2004cited by this paper
• Cooperative Autocrine and Paracrine Functions of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in the Progression of Skin Carcinoma Cells

  2004cited by this paper
• Cytokines IL-1α, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon γ

  2003cited by this paper
• Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck

  2003cited by this paper
• Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.

  2003cited by this paper
• Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

  2003cited by this paper
• Angiogenesis: Tumorigenesis and the angiogenic switch

  2003cited by this paper
• Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression.

  2003cited by this paper
• The Value of Adjuvant Treatment in Young Women with Breast Cancer

  2002cited by this paper
• MIB-1 Labeling Index in Feline Dysplastic and Neoplastic Mammary Lesions and Its Relationship with Postsurgical Prognosis

  2002cited by this paper
• Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.

  2002cited by this paper
• Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis.

  2002cited by this paper
• Colony-Stimulating Factors for the Management of Neutropenia in Cancer Patients

  2002cited by this paper
• Granulocyte colony‐stimulating factor (G‐CSF)‐mediated signaling regulates type IV collagenase activity in head and neck cancer cells

  2001cited by this paper
• Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

  2001cited by this paper
• Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms.

  2001cited by this paper
• Inflammatory Cells and Cancer

  2001cited by this paper
• Increased Levels of Immune Inhibitory Cd34+ Progenitor Cells in the Peripheral Blood of Patients with Node Positive Headc and Neck Squamous Cell Carcinomas and The Ability of These CD34+ Cells to Differentiate Into Immune Stimulatory Dendritic Cells

  2001cited by this paper
• Tumor‐related leukocytosis is linked with poor prognosis in patients with lung carcinoma

  2001cited by this paper
• Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization.

  2001cited by this paper
• Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

  2001cited by this paper
• c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin.

  2000cited by this paper
• Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells.

  2000cited by this paper
• Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression

  2000cited by this paper
• Targeting angiogenesis inhibits tumor infiltration and expression of the pro‐invasive protein SPARC

  2000cited by this paper
• 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.

  2000cited by this paper
• Research controversies in management of oral mucositis

  2000cited by this paper
• The cancer patient with severe mucositis

  2000cited by this paper
• New cytokine dressings. II. Stimulation of oxidative burst in leucocytes in vitro and reduction of viable bacteria within an infected wound.

  1999cited by this paper
• Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression.

  1999cited by this paper
• Granulocyte, granulocyte–macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells

  1999cited by this paper
• Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.

  1999cited by this paper
• Constitutive expression of G‐CSF and GM‐CSF in human skin carcinoma cells with functional consequence for tumor progression

  1999cited by this paper
• Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture.

  1998cited by this paper
• Mutagenesis induced by the tumor microenvironment.

  1998cited by this paper
• Functional evidence for tumor‐suppressor activity on chromosome 15 in human skin carcinoma cells and thrombospondin‐1 as the potential suppressor

  1997cited by this paper
• Halting angiogenesis suppresses carcinoma cell invasion

  1997cited by this paper
• Routine testing of cell cultures and their products for mycoplasma contamination.

  1997cited by this paper
• Granulocyte and macrophage colony-stimulating factors stimulate proliferation of human keratinocytes

  1997cited by this paper
• Comparison of p53 and MIB1 expression in benign and borderline areas of ovarian serous tumors.

  1996cited by this paper
• American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.

  1994cited by this paper
• Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells

  1993cited by this paper
• Basic biology of the hematopoietic growth factors.

  1992cited by this paper
• Hematopoietic growth factors.

  1992cited by this paper
• Basic biology of the hematopoietic growth factors.

  1992cited by this paper
• Granulocyte colony-stimulating factor and its receptor.

  1991cited by this paper
• A correlation between GM‐CSF gene expression and metastases in murine tumors

  1991cited by this paper
• Hematopoietic growth factors.

  1990cited by this paper
• c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy.

  1990cited by this paper
• Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

  1989cited by this paper
• [Inflammation and cancer].

  1974cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• G-CSF promotes H3K27ac-modified KLF5 to activate CXCR4 expression and drive colon cancer growth and metastasis

  2026cites this paper
• N4BP1 is essential for the development of oral cancer via controlling both cancer cells and immune microenvironment

  2026cites this paper
• Tumour-resident oncolytic bacteria trigger potent anticancer effects through selective intratumoural thrombosis and necrosis

  2025influential citation
• Adverse prognosis of GM-CSF expression in human cutaneous melanoma

  2025cites this paper
• Programmed cell death regulates hematopoietic cell homeostasis under radiation conditions

  2025cites this paper
• Innate immune cells in oral squamous cell carcinoma: Characteristics and therapeutic potential.

  2025cites this paper
• Causal relationship between inflammatory factors and gynecological cancer: a Bayesian Mendelian randomization study

  2024cites this paper
• Effect of colony‑stimulating factor in the mechanism of bone metastasis development (Review)

  2024cites this paper
• Ganoderma spore lipid ameliorates docetaxel, cisplatin, and 5-fluorouracil chemotherapy-induced damage to bone marrow mesenchymal stem cells and hematopoiesis

  2024cites this paper
• Schwann cell promotes macrophage recruitment through IL-17B/IL-17RB pathway in injured peripheral nerves.

  2024cites this paper
• Immune Evasion of G-CSF and GM-CSF in Lung Cancer

  2023cites this paper
• The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment

  2023cites this paper
• Autophagy modulators influence the content of important signalling molecules in PS-positive extracellular vesicles

  2023cites this paper
• Pretreatment hematological parameters as predictors of tumor granulocyte-colony-stimulating factor expression in patients of head-and-neck squamous cell carcinoma

  2023cites this paper
• Hematopoietic colony-stimulating factors in head and neck cancers: Recent advances and therapeutic challenges.

  2023cites this paper
• Squamous cell carcinoma‐derived G‐CSF promotes tumor growth and metastasis in mice through neutrophil recruitment and tumor cell proliferation, associated with poor prognosis of the patients

  2023cites this paper
• Granulocyte colony stimulating factor is a novel mediator of T cell suppression and an immunotherapeutic target for women with colon cancer.

  2023cites this paper
• The role of granulocyte-macrophage colony-stimulating factor in head and neck cancer.

  2023cites this paper
• Intratumoral delivery of immune therapy and gene therapy: the next era for cancer therapy.

  2023cites this paper
• Myelosuppression Alleviation and Hematopoietic Regeneration by Tetrahedral‐Framework Nucleic‐Acid Nanostructures Functionalized with Osteogenic Growth Peptide

  2022cites this paper
• Leveraging Tissue Engineering for Skin Cancer Models.

  2022cites this paper
• Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF

  2022cites this paper
• Oral Cancer Cells Release Vesicles that Cause Pain

  2022cites this paper
• rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy

  2022cites this paper
• GM-CSF-miRNA-Jak2/Stat3 Signaling Mediates Chemotherapy-Induced Cancer Cell Stemness in Gastric Cancer

  2022cites this paper
• Two birds with one stone: YQSSF regulates both proliferation and apoptosis of bone marrow cells to relieve chemotherapy-induced myelosuppression.

  2022cites this paper
• Roles of Neutrophils in Glioma and Brain Metastases

  2021cites this paper
• Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints

  2021cites this paper
• Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

  2021cites this paper
• Proinflammatory Signaling Pathways and Genomic Signatures in Head and Neck Cancers

  2021cites this paper
• Epigenetic modulation of the tumor microenvironment in head and neck cancer: challenges and opportunities.

  2021cites this paper
• Recombinant Human Granulocyte Colony-Stimulating Factor is Associated with Increased Risk of Metastasis in NSCLC Patients Following Postoperative Chemotherapy: A Retrospective Cohort Study

  2021cites this paper
• Inflammatory cells in tumor microenvironment

  2021cites this paper
• ZhenQi FuZheng Formula Improves Mouse Hematopoietic Function after Cyclophosphamide-Induced Damage via Enhancing Macrophage Colony-Stimulating Factor Concentrations

  2020cites this paper
• Paraneoplastic leukemoid reaction: Case report and review of the literature.

  2020cites this paper
• Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia

  2020cites this paper
• Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer

  2020cites this paper
• Genomic analysis of the prognostic value of colony-stimulating factors (CSFs) and colony-stimulating factor receptors (CSFRs) across 24 solid cancer types

  2020cites this paper
• Leukocytosis and thrombocytosis as prognostic factors for women with uterine cervical cancer

  2020cites this paper
• G-CSF and G-CSFR Induce a Pro-Tumorigenic Macrophage Phenotype to Promote Colon and Pancreas Tumor Growth

  2020cites this paper
• Targeting tumor-associated macrophages in head and neck squamous cell carcinoma.

  2020cites this paper
• Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia

  2020cites this paper
• Jian-Pi-Bu-Xue-Formula Alleviates Cyclophosphamide-Induced Myelosuppression via Up-Regulating NRF2/HO1/NQO1 Signaling

  2020cites this paper
• Tumour-associated neutrophils in patients with cancer

  2019cites this paper
• Immunologische Aspekte in der Reproduktionsmedizin

  2019cites this paper
• HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma.

  2019cites this paper
• Hematopoietic growth factors and tumor angiogenesis.

  2019cites this paper
• Characterisation of immune-modulating lymphocyte populations in melanoma patients

  2019cites this paper
• Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’

  2019cites this paper
• A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 2 (Radiation Oncology)

  2019cites this paper
• A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 3 (Medical Oncology)

  2019cites this paper
• Prognostic Role of Blood NETosis in the Progression of Head and Neck Cancer

  2019cites this paper
• Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice

  2018cites this paper
• Androgen and Androgen Receptor as Enhancers of M2 Macrophage Polarization in Allergic Lung Inflammation

  2018cites this paper
• Granulocyte Colony-Stimulating Factor Treatment During Radiotherapy Is Associated With Survival Benefit in Patients With Lung Cancer

  2018cites this paper
• Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment

  2018cites this paper
• The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression

  2018cites this paper
• Role of the β Common (βc) Family of Cytokines in Health and Disease.

  2018cites this paper
• Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma

  2017cites this paper
• CD114: A New Member of the Neural Crest‐Derived Cancer Stem Cell Marker Family

  2017cites this paper
• Cutaneous squamous cell carcinoma treated with preoperative intraarterial chemoradiation therapy

  2017cites this paper
• Increased FSHD region gene1 expression reduces in vitro cell migration, invasion, and angiogenesis, ex vivo supported by reduced expression in tumors

  2017cites this paper
• 3D modeling of cancer stem cell niche

  2017cites this paper
• The Contribution of Immune Cells to Angiogenesis in Inflammation and Tumor Growth

  2017cites this paper
• An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer

  2017cites this paper
• Role of the b Common ( b c) Family of Cytokines in Health and Disease

  2017cites this paper
• Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes

  2017cites this paper
• Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model

  2017cites this paper
• Development of a Tissue-Engineered Oral Mucosa Model to Investigate the Role of Tumour-Associated Macrophages in Oral Cancer Progression

  2017cites this paper
• GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation.

  2016cites this paper
• Granulocyte colony-stimulating factor (G-CSF) upregulates β1 integrin and increases migration of human trophoblast Swan 71 cells via PI3K and MAPK activation.

  2016cites this paper
• Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types

  2016cites this paper
• Effect of G-CSF on oral mucositis and traumatic ulcers produced in the tongue of rats undergoing radiotherapy: clinical and histologic evaluation.

  2016cites this paper
• Back to the Problem Of Tumor-Associated Macrophages: A Role For Diagnostic Imaging?

  2015cites this paper
• Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer

  2015cites this paper
• Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact

  2015cites this paper
• Tumor‐induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression

  2015cites this paper
• Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case

  2015cites this paper
• Optimisation of the Lister strain of vaccinia virus for use as an anticancer immunotherapeutic agent

  2015cites this paper
• PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation

  2014influential citation
• The Immune System in Head and Neck Squamous Cell Carcinoma: Interactions and Therapeutic Opportunities

  2014cites this paper
• Immunité et cancers des voies aéro-digestives supérieures 1re partie : Réponses immunitaires et échappement tumoral

  2014cites this paper
• Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications.

  2014cites this paper
• Myofibroblasts in oral lesions: A review

  2014cites this paper
• The granulocyte colony-stimulating factor (G-CSF) upregulates metalloproteinase-2 and VEGF through PI3K/Akt and Erk1/2 activation in human trophoblast Swan 71 cells.

  2014cites this paper
• G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration

  2014influential citation
• Control of Pro-Angiogenic Cytokine mRNA Half-Life in Cancer: The Role of AU-Rich Elements and Associated Proteins

  2014cites this paper
• The use of MuGard™, Caphosol ® and Episil ® in patients undergoing chemoradiotherapy for squamous cell carcinoma of the head and neck

  2014cites this paper
• Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study

  2014cites this paper
• Assessing the effects of radiotherapy on head and neck squamous cell carcinoma using microfluidic techniques

  2013cites this paper
• Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer

  2013cites this paper
• A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma.

  2013cites this paper
• Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer.

  2013cites this paper
• The Incidence of Tumor Cell Contamination of Peripheral Blood Stem Cells: A Meta-Analysis to Evaluate the Impact of Mobilization Regimens and the Influence on Outcomes in Breast Cancer Patients

  2013cites this paper
• Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression

  2013cites this paper
• Molecular cloning, recombinant expression and characterization of GMCSF from the rhesus monkey, Macaca mulatta.

  2013cites this paper
• Nod-like receptors in head and neck squamous cell carcinoma

  2013cites this paper
• Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.

  2013cites this paper
• The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma

  2012cites this paper
• Granulocyte Colony-Stimulating Factor Improves Cerebrovascular Reserve Capacity by Enhancing Collateral Growth in the Circle of Willis

  2012cites this paper